Comparison of Two Moldable Calcium Phosphate-Based Bone Graft Materials in a Noninstrumented Canine Interspinous Implantation Model by Barbieri, D et al.
1 
1 
 
T
is
su
e 
E
n
g
in
ee
ri
n
g
 
C
o
m
p
ar
is
o
n
 o
f 
tw
o
 m
o
ld
ab
le
 c
al
ci
u
m
 p
h
o
sp
h
at
e
-b
as
ed
 b
o
n
e 
g
ra
ft
 m
at
er
ia
ls
 i
n
 a
 n
o
n
-i
n
st
ru
m
en
te
d
 c
an
in
e 
in
te
rs
p
in
o
u
s 
im
p
la
n
ta
ti
o
n
 m
o
d
el
 (
d
o
i:
 1
0
.1
0
8
9
/t
en
.T
E
A
.2
0
1
6
.0
3
4
7
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
Comparison of two moldable calcium phosphate-based bone graft materials in a non-
instrumented canine interspinous implantation model 
 
Davide Barbieri
a,b
, Huipin Yuan
b,c,d, Ali Sait Ismailoğlue, Joost D. de Bruijna,b,f 
 
a Biomaterial Science and Technology, MIRA Institute, University of Twente, Enschede, the Netherlands 
b Xpand Biotechnology BV, Bilthoven, the Netherlands 
c Complex Tissue Regeneration, MERLN Institute, Maastricht University, Maastricht, the Netherlands 
d College of Physical Science and Technology, Sichuan University, Chengdu, China 
e NuVasive Inc., San Diego, United States  
f Queen Mary University of London, School of Engineering and Materials Science, London, United Kingdom  
 
Address correspondence to:  
Davide Barbieri, PhD 
Xpand Biotechnology BV 
Prof. Bronkhorstlaan 10, building 48 
3723 MB Bilthoven, the Netherlands 
E-mail: davide.barbieri@xpand-biotech.com   
 
Huipin Yuan, PhD 
Complex Tissue Regeneration 
MERLN Institute, Maastricht University,  
Maastricht, the Netherlands  
E-mail: h.yuan@maastrichtuniversity.nl   
 
Conflict of interest: 
Davide Barbieri is employee of Xpand Biotechnology BV. 
Huipin Yuan is employee and shareholder of Xpand Biotechnology BV. 
Ali Sait Ismailoğlu is employee of NuVasive Inc.  
Joost D. de Bruijn is employee and shareholder of Xpand Biotechnology BV. 
 
 
 
 
 
 
Tissue Engineering 
                        © Mary Ann Liebert, Inc.  
                        DOI: 10.1089/ten.TEA.2016.0347 
 Page 1 of 30 
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
A
Co
m
pa
ris
on
 o
f t
w
o 
m
ol
da
bl
e 
ca
lc
iu
m
 p
ho
sp
ha
te
-b
as
ed
 b
on
e 
gr
af
t m
at
er
ia
ls 
in
 a
 n
on
-in
str
um
en
te
d 
ca
ni
ne
 in
te
rs
pi
no
us
 im
pl
an
ta
tio
n 
m
od
el
 (d
oi:
 10
.10
89
/te
n.T
EA
.20
16
.03
47
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
2 
2 
 
T
is
su
e 
E
n
g
in
ee
ri
n
g
 
C
o
m
p
ar
is
o
n
 o
f 
tw
o
 m
o
ld
ab
le
 c
al
ci
u
m
 p
h
o
sp
h
at
e
-b
as
ed
 b
o
n
e 
g
ra
ft
 m
at
er
ia
ls
 i
n
 a
 n
o
n
-i
n
st
ru
m
en
te
d
 c
an
in
e 
in
te
rs
p
in
o
u
s 
im
p
la
n
ta
ti
o
n
 m
o
d
el
 (
d
o
i:
 1
0
.1
0
8
9
/t
en
.T
E
A
.2
0
1
6
.0
3
4
7
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
Abstract  
There is a continuing search for novel synthetic materials as an alternative to autologous bone grafting. Different 
technologies are explored to promote bone formation, which include the addition of BioGlass
TM
 particles in 
calcium phosphate (CaP) based materials and the use of surface modification in the form of submicron surface 
topographies. In this work we aimed at comparing the bone formation in a non-instrumented canine interspinous 
(IS) model of moldable formulations of a submicron surface structured tricalcium phosphate/alkylene oxide 
(CaP/AOC) or a tricalcium phosphate/BioGlass
TM
/collagen (CaP/BG/C) bone graft material. Intramuscular 
implantation was carried out as well to evaluate soft tissue responses. 
Eight mature male mongrel dogs underwent single-level, non-instrumented interspinous implantation, where the 
bone graft materials were implanted at either side of the spinous processes (L3-L4), with separation by the 
interspinous ligament ensuring comparison of both materials in each animal (n=8 per material). The materials 
were also implanted in paraspinal muscle pouches. Animals were euthanized 12 weeks after surgery and the 
lumbar spines excised and intramuscular implants retrieved. Un-decalcified sections were prepared for 
histological evaluation and histomorphometry was performed to quantify bone formation and material resorption. 
After 12 weeks all submicron structured CaP/AOC implants showed abundant bone formation in the (L3-L4) 
interspinous space (20.8±6.8%), while bone was not found in the CaP/BG/C implants (0±0%). Intramuscularly, 
the CaP/AOC material triggered significant bone formation (12.0±7.8%), while CaP/BG/C did not form any 
bone. In both the spinal and muscular sites, resorption of the CaP/AOC material was evident by a decrease in 
Feret diameter of the CaP granules as well as in their histological surface compared to the starting material, 
while CaP/BG/C material had a milder resorption. This study shows that a submicron surface structured 
CaP/AOC bone graft material has superior bone forming properties in both an interspinous implantation model 
and intramuscularly, as compared to a CaP/BG/C bone graft material.  
 
Keywords: Bone graft; Calcium phosphate; Submicron structured; Bioglass; Osteoinduction; Spinal fusion.  
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Introduction 
Many conditions that cause pain and instability of the vertebral column (e.g.  degenerative disc disease, scoliosis 
and trauma) require spinal fusion using bone graft materials [1]. Since bone formation is crucial in these 
interventions, the ability of the graft material to regenerate bone should be considered during surgical planning. 
Autologous bone is currently the gold standard bone graft material but its disadvantages (limited availability, 
donor site morbidity and post-operative pain) have motivated researchers to look for alternatives [1].  
Calcium phosphate (CaP) ceramics mimic the chemistry of bone mineral and allow precipitation of bioactive 
bone-like apatite from body fluids on their surface, which facilitates the infiltration of the host’s tissues and cells 
ultimately leading to bone formation [2]. They are therefore the most often used synthetic biomaterials in bone 
repair [3-7], although their bone regenerative potential is limited due to the lack of osteogenic and osteoinductive 
properties. To improve the bone forming ability of CaP ceramics, osteogenic cells may be introduced into 
synthetics through cell therapy techniques (e.g. bone marrow aspirate) [8], while growth factors (e.g. BMPs and 
PDGF) [9] or gene-transfected growth factor-producing cells [10] could also be used. A combination of these 
approaches may produce a material with comparable bone forming potential to autograft, but it would still not be 
the ideal solution because of high costs and complex manufacturing that often lead to not ‘off-the-shelf’ products.  
A promising way to improve the bone forming ability of CaP ceramics is by controlling their physicochemical 
properties such as geometry [11], surface microstructure [12] and chemistry [13]. Surface structural features 
have particularly been shown essential for enhanced bone formation. For instance, the absence of micropores 
smaller than 10 m led to decreased bone formation of CaP ceramics [12, 14], while decreasing the surface 
topographical features showed that resorbable submicron structured tricalcium phosphate (TCP) ceramics are 
osteoinductive in ectopic sites [5, 15] and have enhanced bone formation in orthotopic sites [16] and a spinal 
environment [17]. Next to physical modifications of the surface structure, the introduction of ions such as silicon 
has also been reported to improve the bone forming ability of CaP ceramics [18, 19]. Enhanced formation of 
bone-like apatite and the release of ions (i.e. Ca
2+
, Na
+
 and Si
4+
) are thought to enhance bone formation of CaP 
ceramics [18] combined with bioactive glasses such as BioGlass
TM
 [20]. 
The objective of the present study was to employ a non-instrumented canine interspinous (IS) implantation 
model to compare two commercially available moldable synthetic bone graft materials based on either, a surface 
microstructuring technology (AttraX
®
 Putty) or a BioGlass
TM
 based technology (Vitoss
TM
 BA). Both materials 
were also implanted intramuscularly to evaluate soft tissue responses.   
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Materials and methods 
Bone graft materials and characterization 
A calcium phosphate/alkylene oxide copolymer (CaP/AOC) putty material (AttraX Putty
®
, NuVasive Inc., San 
Diego, USA) and a CaP/BioGlass
TM
/collagen (CaP/BG/C) composite material (Vitoss
TM 
BA, Orthovita 
Inc./Stryker Corp., Kalamazoo, USA) were obtained from the manufacturers. The CaP/AOC was ready for use, 
while CaP/BG/C was provided in two separated components, BioGlass
TM
 granules and a CaP/collagen foam strip. 
The CaP granules were extracted from the AOC and collagen strip by placing the materials in sinter oven (P320, 
Nabertherm, Lilienthal, Germany) at 800°C for three hours and were then characterized. Prior burning out, the 
samples were weighed to allow the determination of their composition (by weight) in CaP, BG and organic 
phases. The chemistry of the CaP granules was analyzed via X-ray diffractometry (XRD; MiniFlex II, Rigaku, 
Tokyo, Japan), while scanning electron microscopy (SEM; XL30, ESEM-FEG, Philips, Eindhoven, the 
Netherlands) was employed to observe the surface structure. Granules of both materials were also analyzed with 
mercury intrusion porosimetry (Micromeritics Instrument Corporation, Norcross, GA, USA) to obtain 
information on total porosity (i.e. the volume percentage of pores in the materials), macroporosity (i.e. the 
volume percentage of pores greater than, or equal, to 10 m in the materials), microporosity (i.e. the volume 
percentage of pores smaller than 10 m in the materials), pore size distribution in the ceramic strut and specific 
surface area. The organic component of CaP/BG/C is declared as collagen type I by the supplier, and is a well-
known material, thus was not further analyzed. On the contrary, AOC formulation is not precisely claimed by the 
commercial supplier and is described in the patent US 8,124,687 B2. Therefore, CaP/AOC putty was immersed 
in chloroform for 12 hour to obtain a supernatant, which was then separated from the CaP granules via 
decantation. The obtained solution was then placed in an oven at 40°C overnight, under vacuum extraction, to 
finally get a sticky paste-like material (i.e. the AOC component). This paste was subjected to proton nuclear 
magnetic resonance spectroscopy (
1H
NMR; Bruker Ascend 400/Avance III, Bruker, Leiderdorp, the Netherlands); 
d-chloroform, 400 MHz) and attenuated total reflectance Fourier transform infra-red spectroscopy (ATR-FTIR; 
Spectrum Two, Perkin Elmer, Groningen, the Netherlands; ZnSe crystal) to determine its chemistry.  
 
Surgical procedure, necropsy and tissue collection 
A canine interspinous (IS) implantation model [17] was used to compare bone formation with the two synthetic 
bone graft materials. The model is a modification from Muschler et al. [21, 22] in that instrumentation was not 
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used to immobilize the spine, while the lamina and facet joints were left intact. Soft tissue response to the 
synthetic bone substitute materials was determined after intramuscular implantation [5, 17, 23].      
Surgery was performed on eight adult dogs (mongrel, male, 10-15 kg, 1-2 year old) at the facility of Chengdu 
Dossy Experimental Animals Co. Ltd. (Chengdu, China), which is licensed to perform animal experiments 
(License no. SYXK (CHUAN) 2014-189, issued by the management committee for animal experiments of 
Sichuan province). All surgeries were conducted under general anesthesia by an abdominal injection of sodium 
pentobarbital (30 mg/kg body weight; Merck, Darmstadt, Germany). After shaving and cleaning the surgical site 
with iodine, longitudinal skin and median fascial incisions were made. The paraspinal muscles were retracted to 
expose the spinous processes at the L3 and L4 levels. Tissues at both sides of the spine were separated from the 
intra- and supra-spinous ligaments to create two implantation beds next to the L3 and L4 spinous processes. 
After superficial decortication of either side of the spinous processes with a rasp to create punctate bleeding, 5 cc 
of each graft material (Figure 1) was placed at either side of the spinal ridge to bridge the two spinous processes 
according to a randomization schedule. CaP/AOC was used as received (Figure 1) and shaped to fit the defect, 
while CaP/BG/C was prepared according to the manufacturer’s instructions. In short, one gram of BioglassTM 
granules were loaded onto the surface of the TCP/collagen foam strip (10 cc), which was then wet with 9 ml 
physiological saline and mixed thoroughly to uniformly combine the components. Half of the prepared 
CaP/BG/C composite (i.e. 5 cc, Figure 1) was shaped into the spinous defect, while one cc was used for 
intramuscular implantation as described later. Once both materials were placed in the spinous defects, the 
muscles from both sides were tightly closed with silk suture. Subsequently, two paraspinal muscle pouches were 
created with blunt separation at least 3 cm away from the spinal bone. One cc of CaP/AOC putty or one cc of 
CaP/BG/C composite was implanted in each muscle pouch and sealed with silk suture. The wound was finally 
closed layer by layer with silk sutures. Following surgery, the animals were intramuscularly given buprenorphine 
(0.1 mg per animal; Merck) for two days to relieve pain and penicillin (40 mg/kg; Merck) for three days to 
prevent infection. The animals were allowed full weight bearing and received a normal diet. Calcein (10 mg/kg 
body weight; Sigma-Aldrich, Steinheim, Germany) was intravenously injected six weeks after implantation to 
monitor the onset of bone formation. Animals were euthanized at 12 weeks by a barbiturate overdose and the 
lumbar spines excised and intramuscular implants were harvested with surrounding tissues.   
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Histology and histomorphometry 
The explants were trimmed, fixed in 4% formaldehyde (Sigma-Aldrich) and dehydrated through a series of 
ethanol (Sigma-Aldrich) prior to embedding in methyl methacrylate (L.T.I., Bilthoven, the Netherlands) using 
standard techniques. Non-decalcified sections were made using a diamond saw (SP-1600; Leica, Mannheim, 
Germany) and stained with 1% methylene blue (Sigma-Aldrich) and 0.3% basic fuchsin (Sigma-Aldrich) for 
light microscopy and histomorphometric analysis. Fluorescent microscopy was performed on unstained sections 
using a FITC Texas Red filter (band-pass mirror wavelengths of 510-555 nm and 585-665 nm; Nikon, Tokyo, 
Japan). The spines were sectioned in the coronal plane, while cross sections of the intramuscular samples were 
made. Histomorphometric analysis was done on scanned stained slides (Dimage Scan Elite5400 II, model 
AF5400-2; Konica Minolta, Tokyo, Japan). Bone formation was quantified using the histogram function in 
Adobe Photoshop (CS5, v12; Adobe Systems Benelux BV, Amsterdam, the Netherlands). The area adjacent to 
and between both (L3-L4) spinous processes was selected as region of interest (ROI) and the number of pixels 
was read. The ROI for the intramuscular samples was determined as the area of material encapsulated by a thin 
connective tissue layer. After determining the ROI, material and bone were pseudo-colored and pixels read as M 
and B respectively. The area percentage of bone in the available space was calculated as B100/(ROI-M). Bone 
contact with the surface of the granules was determined as the ratio 100*PB/PG, where PB is the perimeter of 
bone in direct contact with the surface of the granules, while PG is the perimeter of all the granules in the ROI. 
The perimeters were measured using the ‘analyze/measure’ function in ImageJ (v1.43u, NIH, Bethesda, USA).   
The in vivo resorption rate was assessed via measuring the change in the histological area (i.e. the amount of 
pixels belonging to CaP and BG components, normalized to the ROI) in the explants. For this latter 
measurement, sections made from MMA blocks containing the starting amounts of CaP and CaP/BG in the two 
grafts (after burning AOC and collagen out at 800°C for three hours) were used as time zero controls. 
A further demonstration of material resorption was given by comparing the average maximum Feret diameters of 
the CaP granules prior to and after implantation. For this measurement, sections made from MMA blocks 
containing the starting ceramic granules were used as time zero controls. Before extracting the diameters, all 
images (at least three slides of each sample) were pre-processed to remove background noise and objects of no 
interest (e.g. bone tissue) using Adobe Photoshop. Afterwards, by using ImageJ, the images were converted into 
a binary format and analyzed using the ‘analyze particles’ algorithm to finally measure the maximum Feret 
diameters. The total number of granules measured was about 2000 and the diameters were expressed as mean 
and standard deviation. Diameters were taken of the longest and shortest length of the granules, provided that 
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they were perpendicular with each other. However, they could be measured only for CaP/AOC samples because 
severe fragmentation of the CaP granules in CaP/BG/C rendered it impossible to adequately determine their 
diameters.  
 
Statistical analysis 
Statistical analysis was performed using the two tail t-test with significance defined as p<0.05. The power of 
both spine and muscular experiments was determined with a post-hoc power analysis (two-tail t-test for 
difference in mean) using the freeware G*Power software [24].  
 
Results 
Characterization of the bone graft materials 
After burning out AOC and collagen, the content by weight of each component in the two grafts was determined 
(Table 1). X-ray diffraction showed that the ceramic component in CaP/AOC was comprised of tricalcium 
phosphate (96% wt.) with a minor phase of hydroxyapatite (Figure 2a, Table 1), while the ceramic component in 
CaP/BG/C was pure tricalcium phosphate. Scanning electron microscopy revealed that the CaP of both materials 
had a different surface topography and consisted of grains that were different in size (Figures 2c and 2d). The 
ceramic from CaP/AOC had submicron-sized grains (0.8-1.1 micrometer) and pores (0.3-1.1 micrometer), while 
the grain and micropore size of the ceramic in CaP/BG/C were 1.9-3.1 micrometer and 0.5-4.5 micrometer, 
respectively. These findings were corroborated by the mercury intrusion data (Figure 2b and Table 1), which 
demonstrated that the ceramic phase of CaP/AOC had a significant larger component of submicron-sized pores 
than the ceramic in CaP/BG/C. As already mentioned earlier, collagen type I is the organic component of 
CaP/BG/C material (Table 1). The binder of CaP/AOC was identified (via 
1H
NMR and FTIR) as a mixture, or 
copolymer, of poly(ethylene glycol) (PEG) and poly(propylene glycol) (PPG) (Table 1), confirming that AOC is 
a Poloxamer-based formulation as already published elsewhere [25].      
 
Surgery 
Both materials were moldable and could be handled in an acceptable fashion during implantation. However, 
during the preparation of CaP/BG/C composite, it was observed that it decreased its volume of about 30% when 
it was hydrated with physiological saline. Afterwards, we could cut the obtained CaP/BG/C composite into a 5 
cc sample (for the spine site, Figure 1) and a 1 cc sample for the intramuscular implantation. The surgical 
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procedure was uneventful and no post-operative complications were observed. One animal died after nine weeks 
due to causes unrelated to the experiment and was excluded from the study. 
  
Histology and histomorphometry of the interspinous (IS) implants  
After 12 weeks of implantation, the CaP/AOC implants had largely retained their shape and were larger in 
volume as compared to the CaP/BG/C implants that seemed to have collapsed (Figure 3). Formation of new bone 
tissue was observed throughout the CaP/AOC implants (20.8±6.8% in the available space of the ROI, with a 
bone/granule contact of 24.1±5.9%), while it was absent in CaP/BG/C implants. Bone was not homogenously 
distributed between L3-L4 in the CaP/AOC implants and solid spinal fusion was therefore not achieved (Figure 
3). In particular, more bone tissue formed in the regions next to the spinous processes (Figure 4) while less was 
seen in the central area between both processes. In this central area, fibrous cartilage tissue formation was often 
detected (Figure 5). Interestingly, bone formation also occurred far away from the host bone bed of the 
CaP/AOC implants. When observed in detail, the regions closest to the spinous processes presented osteoid, 
mineralized bone and bone marrow (Figure 4), while further away from the host bone bed also fibrous cartilage 
was observed (Figure 5a).  
Resorption of the ceramic granules in CaP/AOC implants was more pronounced in sites distant from the host 
bone as indicated by the presence of small fragments taken up by giant cells (Figures 5 and 6). Quantitative 
measurements on the CaP granules showed a 50.8% and 54.9% reductions in their histological area and Feret 
diameter, respectively, compared to the pre-implantation samples (Table 2). These results confirm that resorption 
of the ceramic granules in CaP/AOC spine explants occurred over a time span of 12 weeks.   
A limited amount of bone had formed between the spinous processes in CaP/BG/C implants (0±0%). Even close 
to the host bone bed, new bone formation was sporadically seen (Figure 7a). Fragments of TCP granules were 
seen phagocytized by giant cells and were sometimes embedded in areas of new bone formation (Figure 7b). 
Fibrous tissue was usually seen infiltrating between the granules of BioGlass
TM
 and TCP fragments (Figures 3 
and 8). The severe fragmentation of the CaP/BG/C implants may have led to their collapse in the surgical site, 
and hindered the ability to quantify its resorption rate via the Feret diameter. However, it was possible to 
measure the histological area of the TCP material (i.e. remaining granules and fragmented residuals) and 
BioGlass
TM
 fragments. In particular, the area of the TCP and BioGlass
TM
 components decreased by 37.6% and 
32.9% respectively (Table 2), indicating that resorption of TCP and dissolution of BioGlass
TM 
particles occurred 
after 12 weeks implantation.   
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Fluorescence microscopy showed a calcein label in the host bone (i.e. the spinous processes) and in the 
CaP/AOC and CaP/BG/C implants (Figure 9a). Calcein labels were mainly observed in areas of new bone 
formation near the host bone bed in the CaP/AOC implants (Figures 9a and 9b). In the CaP/BG/C implants, 
calcein labels were found throughout the implantation area (Figure 9a), where it was uniquely related to the 
surface apatite layer formed on BioGlass
TM
 granules (Figure 9c). This indicates that bone formation in the 
CaP/AOC implants and surface apatite formation on BioGlass
TM
 granules of the CaP/BG/C implants started 
before six weeks.  
 
Tissue response to the intramuscular implants 
CaP/AOC: At harvest, a thin connective tissue layer encapsulated the CaP/AOC explants without clear signs of 
an inflammatory reaction. Histological examination of the explants showed the presence of soft tissues, bone and 
CaP ceramic granules (Figure 10a). Areas of de novo bone formation occurred mainly in the core of the explants 
and the amount of newly formed bone varied among the samples. Quantitatively, 12.0±7.8% mineralized bone 
tissue was seen in the available space of the ROI (i.e. the space between the ceramic granules), while bone 
contact with the granules was 21.9±7.1% (Table 2). The polymer carrier (i.e. AOC
®
) was not observed in any of 
the explants and resorption of the ceramic component was evident by the presence of multi-nucleated cells and 
small ceramic fragments in surrounding phagocytes. Resorption of the ceramic granules varied with their 
location within the implants. At sites where only fibrous tissues were present (Figures 10b and 10c), small 
fragments detached from the ceramic bodies (Figure 10b) and were phagocytized by macrophages and foreign 
body giant cells (Figure 10c). In areas where bone had formed (Figures 10d and 10e), the surface of ceramic 
granules was covered by newly formed bone and the resorption was less pronounced (Figure 10d), and giant 
cells were phagocytosing ceramic fragments (Figure 10e). Resorption of the ceramic occurred in areas of bone 
remodelling, suggesting cell mediated resorption of the ceramic. The pronounced in vivo resorption of the 
ceramic component in CaP/AOC observed histologically was quantitatively corroborated by a significant 
decrease of the area (–39.3%) and Feret diameter (–47.8%) of the granules when compared to the starting 
baseline.  
CaP/BG/C: At harvest, a soft tissue capsule was observed around the CaP/BG/C explants, without clear signs of 
inflammation. Although properly mixed during implant preparation and placement, the BioGlass
TM
 granules 
were mainly present in the core of the explants (Figure 11a) and bone was never observed. The available space 
between the TCP and BioGlass
TM
 granules was infiltrated by fibrous tissues (Figures 11b and 11c) and the 
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collagen component of CaP/BG/C could not be detected. Foreign body giant cells were seen colonizing the 
granules and mineralization occurred on BioGlass
TM
 as suggested by the presence of a dark red layer of basic 
fuchsin stain (Figures 11b and 11c). Similarly to what discussed earlier, fragmentation of the CaP component  
prevented quantitative determination the Feret diameter, but a 20.9% decrease of the histological area was 
measured. Further, the histological area of BioGlass
TM
 particles had a 26.3% decrease over the implantation 
period. 
The 6-week fluorescent signal was not observed in any of the CaP/AOC groups, while it was seen in the 
CaP/BG/C implants (data not provided). As fluorescence was confined to the surface of BioGlass
TM
 granules, it 
suggests the formation of a surface apatite layer. These observations furthermore indicate that intramuscular 
bone formation did not start before six weeks in the CaP/AOC implants. 
 
Discussion 
In this study, we evaluated two moldable CaP-based bone graft materials in a non-instrumented canine 
interspinous model and intramuscularly over a 12 weeks implantation period. The bone forming potential of the 
materials was either ‘enhanced’ by creating a submicron surface topography (i.e. in CaP/AOC) or by adding 
BioGlass
TM
 particles (i.e. in CaP/BG/C). Clear performance differences were observed between both material 
types. Firstly, considerable bone formation and implant resorption was observed with the submicron structured 
CaP/OAC implants in the spine model, while negligible bone formation and severe fragmentation was seen with 
the CaP/BG/C implants. Secondly, although both materials showed a mild inflammatory response after 
intramuscular implantation, de novo bone formation was seen in all CaP/AOC implants while only fibrous tissue 
infiltration was seen in the CaP/BG/C implants. 
The ability of submicron structured ceramic materials such as CaP/AOC to give rise to heterotopic bone 
formation has been reported before [5, 11-16] and is not a new finding. This material property may also have 
contributed to the meaningful bone formation of CaP/AOC observed in the non-instrumented spinal site since 
the CaP/BG/C material was unable to form bone. Muschler et al. reported that providing instrumentation and 
decortication of the lamina and facet joints in a similar spinal fusion model in mongrel dogs is ineffective to 
obtain fusion upon implantation of a collagen ceramic composite graft material, even when mixed with 
cancellous bone graft or autologous bone marrow [21, 22]. These studies also showed that spinal fusion is 
challenging in dog interspinous models because it was not always reached even when using the golden standard 
autograft in presence of instrumentation and decortication [21, 22].  
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Although in our study fusion was also not observed, the presence of cartilaginous tissue in the center of the 
fusion mass with CaP/AOC (Figure 5) is indicative of mechanical instability, which is known to hamper bone 
formation [26, 27]. It is probable that a less sensitive model to the one we used, i.e. using instrumentation and 
decorticating the lamina and facet joints as done by Muschler et al. [21, 22] may have allowed fusion to occur 
with this material. 
In this study the CaP component of the two composites slightly differed since traces of HA were present in the 
inorganic component of CaP/AOC (Figure 2a, Table 1), while pure TCP was found in the CaP component of 
CaP/BG/C. The effects of these chemical differences on bone formation may have been minor compared to the 
potentially larger role of the surface structural dimension. In fact, as recently suggested by Davison et al. (2015) 
in a study testing the influence of several CaP material parameters (surface microstructure, macrostructure and 
surface chemistry), the microstructural dimensions were reported to be the most critical factors promoting bone 
formation [28]. The CaP phase in both graft materials contained micropores (Figure 2c and 2d) with similar 
microporosity, but the granules in CaP/AOC had significantly larger fraction of sub-micron porosity (Figure 2b 
and Table 1). Only the composite containing sub-micron structured material triggered instructive bone formation 
(Figures 10 and 11), suggesting that not only the presence of micropores but also their dimension plays a major 
role in CaP-directed bone formation [5, 15, 17]. It is well known that CaP ceramics can degrade via both 
chemical dissolution and cell-mediated resorption [29]. Intramuscularly, the latter phenomenon appeared 
histologically evident in CaP/AOC and less in CAP/BG/C (Figures 10 and 11), which suggests a possible 
influence of the sub-micron structured surface (Figure 2c) on the activity of phagocytes [28-30]. This would be 
in agreement with the findings of Davison et al. (2014) who reported that cell-mediated resorption of 
biomaterials and osteoclastogenesis is a prelude to material-directed bone formation [30].  
Surface mineralization and silicon ion release are reported to enhance the bioactivity of BioGlass
TM
 [19, 20, 31]. 
Although we did observe in vivo surface mineralization on BioGlass
TM
 granules in CaP/BG/C (Figure 9), no 
signs of osteoinduction were detected intramuscularly. In the spine the material was severely fragmented and 
also showed negligible bone formation. Similar disappointing results were reported by Walsh et al. (2013), who 
implanted CaP/BG/C combined with a bone marrow aspirate in a rabbit posterolateral spinal fusion model for up 
to 26 weeks and did not see any bone formation in the middle of the fusion mass [32]. Conversely, Epstein (2009) 
reported successful fusion in humans when the TCP component of CaP/BG/C was implanted in the instrumented 
posterolateral spine [33]. It should be noted that in the study of Epstein (2009), TCP was used in a large volume 
(30 cc granules), mixed with bone marrow aspirate and combined with the same amount of autograft. Similarly, 
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when the same TCP granules were combined with autogenous BMA, it was reported to lead to high fusion rates 
in human posterior cervical spine [34], which suggests the need for autologous bone and osteogenic elements to 
support and enhance the biological activity of the TCP component in CaP/BG/C [32-34]. As a result, this may 
explain why CaP/BG/C was not efficacious in this study.  
Within the limits of this study, the submicron structured CaP/AOC implants supported bone formation in the 
canine non-instrumented interspinous implantation model and showed bone induction after intramuscular 
implantation. Bone formation was not sufficient to achieve a solid fusion, which is likely the result of the non-
instrumented nature of the model [26]. The bone forming potential of CaP/BG/C implants was limited in the 
spine which is likely due to the collapse and severe fragmentation of the implant either during implant 
preparation or after surgical placement and post-operative movement. 
 
5. Conclusions 
The results of this study show that a submicron surface structured CaP/AOC bone graft material has superior 
bone forming properties in both an interspinous implantation model as compared to a CaP/BG/C bone graft 
material. It also shows that the CaP/AOC material has osteoinstructive properties, which could have aided in the 
bone formation shown in the spine. Further investigation is warranted to verify the link between ectopic and 
orthotopic bone formation and the influence of (micro) motion on bone formation in this model.  
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Figure 1. (a) Spinal sample (5 cc) of CaP/BG/C composite after preparing it following the manufacturer’s 
indications, cutting into the desired volume and shaping. (b) Spinal sample (5 cc) of CaP/AOC after shaping.  
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Figure 2. (a) XRD patterns showing the chemistry of the calcium phosphate phase in the two materials: the 
arrow indicates the peak of HA in the biphasic composition of the ceramic component in CaP/AOC composite. 
(b) Volume distribution of micro-/nano- pores within the calcium phosphate phases of CaP/AOC and CaP/BG/C 
materials. SEM images showing the different surface submicron- and micron- structure of the calcium phosphate 
phases of (c) CaP/AOC and (d) CaP/BG/C. (e) 
1H
NMR of the AOC extracted from CaP/AOC showing that it is 
composed of two different polymer components, namely poly(ethylene glycol) (PEG) and poly(propylene glycol) 
(PPG). The typical NMR shifts of each component are indicated as p1 (3.60-3.75 ppm, PEG), p2 and p3 (3.85-
3.95 ppm, PPG), p4 (3.50-3.60 ppm, PPG), p5 (3.40-3.50 ppm, PPG) and p6 (1.10-1.20 ppm, PPG). The symbol 
w indicates the shift for water. (f) ATR-FTIR spectra of the AOC extracted from CaP/AOC confirming that AOC 
is a copolymer, or a mixture, of PEG and PPG. The typical vibrational bands for PEG and PPG are indicated as 
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i1 (2970-2971 cm
-1
, PPG), i2 (2882-2891 cm
-1
, PEG), i3 (1375-1373 cm
-1
, PPG), i4 (1341-1352 cm
-1
, PEG) and i5 
(860-875 cm
-1
, PPG). All the other bands present on the spectra are in common for PEG and PPG.         
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Figure 3. A histological overview (coronal plane) of CaP/AOC (upper) and CaP/BG/C (down) implanted in the 
spine region of dog for 12 weeks, showing bone formation in CaP/AOC and no bone in CaP/BG/C (non-
decalcified section; 1% methylene blue and 0.3% basic fuchsin staining; SP: spinous process; the region between 
the lines is the region of interest for histomorphometrical evaluation regarding bone formation and ceramic 
resorption). The numbers 1 to 5 on the slide indicate the regions whose details are shown at higher magnification 
in Figures 4 to 8.    
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Figure 4. (a) A light microscopic observation of site 3 in Figure 3 showing bone formation in CaP/AOC 
implants nearby the spinous process, and (b) represents the square in (a) at a higher magnification, showing 
mineralized bone, osteoid and bone marrow (cap: calcium phosphate ceramic, nb: new bone; ob: host bone; bm: 
bone marrow). 
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Figure 5. (a) A light microscopic observation of site 4 in Figure 3 showing the tissue response to CaP/AOC 
implants in the region between the two spinous processes, and (b) is the square in (a) at a higher magnification, 
showing calcium phosphate ceramic resorption and bone formation in CaP/AOC implants (cap: calcium 
phosphate ceramic; nb: new bone; fc: fibrous cartilage; cp: ceramic particulate). 
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Figure 6. (a) A light microscopic observation of site 5 in Figure 3 showing the tissue response to CaP/AOC in 
the region far from the host bone beds and (b) is the selected square in (a) at a higher magnification, showing 
fibrous cartilage (cap: calcium phosphate ceramic; nb: new bone; fc: fibrous cartilage; cp: ceramic particulate). 
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Figure 7. (a) Site 1 in Figure 3 at a higher magnification, showing limit conductive bone formation in CaP/BG/C 
from the spinous process and (b) is the square in (a) at a higher magnification, showing fibrous tissues, ceramic 
fragment (cap: calcium phosphate ceramic; nb: new bone). 
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Figure 8. (a) A light microscopic observation of site 2 in Figure 3 showing the tissue response to CaP/BG/C in 
the region between the two spinous processes and (b) is the square in (a) at a higher magnification, showing 
tissue responses to calcium phosphate ceramic particle and BioGlass
TM
 particles respectively (cap: calcium 
phosphate ceramic; bg: BioGlass
TM
). 
 
  
 Page 23 of 30 
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
A
Co
m
pa
ris
on
 o
f t
w
o 
m
ol
da
bl
e 
ca
lc
iu
m
 p
ho
sp
ha
te
-b
as
ed
 b
on
e 
gr
af
t m
at
er
ia
ls 
in
 a
 n
on
-in
str
um
en
te
d 
ca
ni
ne
 in
te
rs
pi
no
us
 im
pl
an
ta
tio
n 
m
od
el
 (d
oi:
 10
.10
89
/te
n.T
EA
.20
16
.03
47
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
24 
24 
 
T
is
su
e 
E
n
g
in
ee
ri
n
g
 
C
o
m
p
ar
is
o
n
 o
f 
tw
o
 m
o
ld
ab
le
 c
al
ci
u
m
 p
h
o
sp
h
at
e
-b
as
ed
 b
o
n
e 
g
ra
ft
 m
at
er
ia
ls
 i
n
 a
 n
o
n
-i
n
st
ru
m
en
te
d
 c
an
in
e 
in
te
rs
p
in
o
u
s 
im
p
la
n
ta
ti
o
n
 m
o
d
el
 (
d
o
i:
 1
0
.1
0
8
9
/t
en
.T
E
A
.2
0
1
6
.0
3
4
7
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
 
 
Figure 9. Fluorescent observations of spinal implants. (a) An overview observation; (b) is the square 1 in (a) at 
a higher magnification showing bone formation nearby the spinous processes within the CaP/AOC implants at 
week 6 and (c) is the square 2 in (a) at the high magnification showing mineralization of BioGlass
TM
 within 
CaP/BG/C implants (SP: spinous process; bg: BioGlass
TM
). 
 
  
 Page 24 of 30
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
A
Co
m
pa
ris
on
 o
f t
w
o 
m
ol
da
bl
e 
ca
lc
iu
m
 p
ho
sp
ha
te
-b
as
ed
 b
on
e 
gr
af
t m
at
er
ia
ls 
in
 a
 n
on
-in
str
um
en
te
d 
ca
ni
ne
 in
te
rs
pi
no
us
 im
pl
an
ta
tio
n 
m
od
el
 (d
oi:
 10
.10
89
/te
n.T
EA
.20
16
.03
47
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
25 
25 
 
T
is
su
e 
E
n
g
in
ee
ri
n
g
 
C
o
m
p
ar
is
o
n
 o
f 
tw
o
 m
o
ld
ab
le
 c
al
ci
u
m
 p
h
o
sp
h
at
e
-b
as
ed
 b
o
n
e 
g
ra
ft
 m
at
er
ia
ls
 i
n
 a
 n
o
n
-i
n
st
ru
m
en
te
d
 c
an
in
e 
in
te
rs
p
in
o
u
s 
im
p
la
n
ta
ti
o
n
 m
o
d
el
 (
d
o
i:
 1
0
.1
0
8
9
/t
en
.T
E
A
.2
0
1
6
.0
3
4
7
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
 
 
Figure 10. Histology of CaP/AOC implanted in muscle of dogs for 12 weeks. (a) A histological overview, (b) 
site 1 in (a) at a higher magnification, showing the degradation of calcium phosphate ceramic, (c) Square in (b) 
at a higher magnification, showing the degradation process of calcium phosphate ceramic, (d) site 2 in (a) at a 
higher magnification, showing bone formation and degradation of calcium phosphate ceramic, (e) the square in 
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(d) at a higher magnification, showing bone remodeling and degradation of calcium phosphate ceramic (un-
decalcified section; 1% methylene blue and 0.3% basic fuchsin staining; cap: calcium phosphate ceramic; gc: 
giant cell; cp: ceramic particulate, nb: new bone; oc: osteclast). 
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Figure 11. Histology of CaP/BG/C after intramuscular implantation in dog for 12 weeks. (a) A histological 
overview, (b) site marked with green star in (a) at a higher magnification, showing the presence of CaP ceramic 
particles and BioGlass
TM
 particles but no bone; (c) the square in (b) at a higher magnification, showing fibrous 
tissues and foreign body giant cells in the implants (non-decalcified section; 1% methylene blue and 0.3% basic 
fuchsin staining; cap: calcium phosphate ceramic; bg: BioGlass
TM
; gc: giant cell). 
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Table 1. General summary of the two synthetic bone grafts. 
 CaP/AOC CaP/BG/C 
Formulation - composition of each phase (on total weight) 
CaP ceramic: 51.7%wt. 
Carrier: 48.3%wt. 
CaP ceramic: 61.8%wt. 
Carrier: 19.5%wt. 
Additives: 18.7%wt. 
CaP ceramic 
Particle size 0.5-1.0 mm 1.0-4.0 mm 
Chemical composition of the CaP 
96% β-TCP 
4% HA 
100% β-TCP 
Porosity 72%  78% 
Grain size 0.8-1.1 m 1.9-3.1 m 
Micropore size 0.3-1.1 m 0.5-4.5 m 
Microporosity (volume percentage of pores <10 µm) 22% 23% 
Submicro/nano-porosity (volume percentage of pores <1 µm) 21% 1% 
Specific surface area  1.846 g/m
2
 0.362 g/m
2
 
Carrier 
Chemistry of the carrier 
Alkylene oxide copolymer (AOC
®
), copolymer or mixture 
of poly(ethylene glycol) (PEG) and poly(propylene glycol) 
(PPG) polymers 
Collagen I 
Dissolution rate of the carrier 24-48 hours n/a 
Additives n/a BioGlass
TM
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Table 2. In vivo performances of the two synthetic bone grafts. The statistical power was calculated for the bone formation in each experiment with post-hoc 
statistical power analysis for t-test of means between two independent groups (significance level at 0.05); the power analysis results show that a number of seven 
animals, carrying both materials, is sufficient in this study for both the muscular and spine experiments. 
 CaP/AOC CaP/BG/C Power (Effect Size) 
Intramuscular samples    
Number of explants 
Bone incidence 
Bone area in available space (%) 
Bone contact (%) 
Resorption of carrier 
Resorption** of CaP granules (%) 
Resorption** of additive (%) 
Variation in Feret diameter of CaP granules (%) 
7 
7/7 
12.0±7.8 
21.9±7.1 
no residuals seen 
39.3 
-- 
47.8 
7 
0/7 
0 
0 
no residuals seen 
20.9 
26.3 
granules severely fragmented*** 
-- 
-- 
0.99 (2.17) 
1.00 (4.36) 
-- 
-- 
-- 
-- 
Spine samples    
Number of explants 
Bone incidence 
Bone area in available space (%) 
Bone contact (%) 
Resorption of carrier 
Resorption** of CaP granules (%) 
Resorption** of additive (%) 
Variation in Feret diameter of CaP granules (%) 
7 
7/7 
20.8±6.8 
24.1±5.9 
no residuals seen 
50.8 
-- 
54.9 
7 
0/7 
0* 
0 
no residuals seen 
37.6 
32.9 
granules severely fragmented*** 
-- 
-- 
0.99 (4.32) 
1.00 (5.77) 
-- 
-- 
-- 
-- 
* traces of bone formation were observed in the close vicinity of the spinous processes. 
** as histologically quantified via the area compared to the starting controls. 
*** as granules were severely fragmented, the Feret diameter could not be measured. 
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License of Usage of Experimental Animals 
License number: SYXK (CHUAN) 2014-189 
Department: Chengdu Dossy Experimental Animals Co. Ltd. 
Legal representative: Wenli Luo 
Address: Xinglong Si street 1, Jiajia town, Jianyang city, Sichuan province, China  
Range of application: minipigs, rabbits, dogs (open system), rats, mice, guinea pigs (barrier system) 
Period of validity: Five years 
Issuing authority:  
The experimental animals management committee of Sichuan province 
Date: 11 April 2014 
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